Rat-derived feeder cells immortalized by expression of mutant CDK4, cyclin D, and telomerase can support stem cell growth.

Biochim Biophys Acta Mol Cell Res

National Institute for Environmental studies, Wildlife Genome Collaborative Research Group, 16-2 Onogawa, Tsukuba, Ibaraki 305-8506, Japan; Iwate University, Graduate School of Science and Engineering, 4-3-5, Ueda, Morioka 020-8551, Japan; Soft-Path Engineering Research Center (SPERC), Iwate University, Morioka, Japan. Electronic address:

Published: May 2019

AI Article Synopsis

  • Stem cells often need feeder cells for maintenance, with primary mouse embryonic fibroblasts (MEFs) being the traditional choice, but they require frequent isolation since they don't expand indefinitely.
  • Immortalized cells like STO have been used as alternatives, but they typically only support stem cell cultures for around 4 to 7 days.
  • This study introduces a new type of rat-derived fibroblast that can be immortalized and supports stem cell cultures for about 14 days, offering a more effective and longer-lasting source for feeder cells in stem cell research.

Article Abstract

The maintenance of stem cells often requires the support of feeder cells. Primary mouse embryonic fibroblasts (MEFs) have traditionally been used as feeder cells, and although these MEF-derived feeder cells have exhibited a reasonable performance, they require repeated cell isolation, since MEFs cannot expand indefinitely. To overcome this limitation, immortalized cells, such as STO cells, have been used. However, one major disadvantage is that previously reported immortalized cells can only support stem cell cultures for a relatively short period, typically 4 to 7 days. In this study, we found that our newly established rat-derived fibroblasts immortalized by the expression of mutant cyclin-dependent kinase 4, cyclin D, and telomerase reverse transcriptase, can function as feeder cells for relatively long cell culture periods of approximately 14 days. The rat-derived immortalized cells developed in this study should be a useful source of feeder cells to support stem cell research.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2019.02.013DOI Listing

Publication Analysis

Top Keywords

feeder cells
24
support stem
12
stem cell
12
immortalized cells
12
cells
11
immortalized expression
8
expression mutant
8
cyclin telomerase
8
cells support
8
immortalized
5

Similar Publications

iPSCs can serve as a renewable source of a consistent edited cell product, overcoming limitations of primary cells. While feeder-free generation of clinical grade iPSC-derived CD8 T cells has been achieved, differentiation of iPSC-derived CD4sp and regulatory T cells requires mouse stromal cells in an artificial thymic organoid. Here we report a serum- and feeder-free differentiation process suitable for large-scale production.

View Article and Find Full Text PDF

Mouse embryonic fibroblasts (MEFs) have been widely used as feeder cells in embryonic stem cell cultures because they can mimic the embryonic microenvironment. Milk fat globule-epidermal growth factor 8 (MFGE8) is expressed during mouse gonadal development, 10.5-13.

View Article and Find Full Text PDF

The generation of germline cells from human induced pluripotent stem cells (hiPSCs) represents a milestone toward in vitro gametogenesis. Methods to recapitulate germline development beyond primordial germ cells in vitro have relied on long-term cell culture, such as 3-dimensional organoid co-culture for ~four months. Using a pipeline with highly parallelized screening, this study identifies combinations of TFs that directly and rapidly convert hiPSCs to induced oogonia-like cells (iOLCs).

View Article and Find Full Text PDF

Objective: Rheumatoid arthritis (RA) is characterized by circulating anti-cyclic citrullinated peptide (CCP) autoantibodies (ACPAs), resulting in inflammation of the joints and other organs. We have established novel assays to assess immune cell subpopulations, including citrullinated antigen-specific (CAS) autoreactive B and T lymphocytes, in patients with RA.

Methods And Results: We found that activated CD25 T cells were markedly increased in patients with RA compared to healthy controls.

View Article and Find Full Text PDF

The clinical potential of current chimeric antigen receptor-engineered T (CAR-T) cell therapy is hampered by its autologous nature that poses considerable challenges in manufacturing, costs and patient selection. This spurs demand for off-the-shelf therapies. Here we introduce an ex vivo feeder-free culture method to differentiate gene-engineered hematopoietic stem and progenitor (HSP) cells into allogeneic invariant natural killer T (NKT) cells and their CAR-armed derivatives (CAR-NKT cells).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!